GE HealthCare Q3 adj EPS $1.14, revenue $4.9B; raises FY margin and EPS guidance

GE HealthCare Technologies Inc.

2024-Q3 EPS reported $2.77 revenue$14,353,000,000

Revenue $4.9B, +1% YoY reported and organic; orders +1% organically, book-to-bill 1.04x.
Adj EPS $1.14 vs $0.99; net income $470M; net margin 9.7% vs 7.8%; Adj EBIT margin 16.3%, +90bps.
Free cash flow $651M vs $570M; cash from ops $742M, +$92M YoY.
FY24 guidance: Adj EPS $4.25-4.35 (prev $4.20-4.35); Adj EBIT margin 15.8-16.0% (prev 15.7-16.0%).
China softness offsets US growth; PDx segment revenue +6% organic; Imaging flat.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.